"Celecoxib" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS, as well as the management of ACUTE PAIN.
| Descriptor ID |
D000068579
|
| MeSH Number(s) |
D02.065.884.247 D02.886.590.700.247 D03.383.129.539.160
|
| Concept/Terms |
Celecoxib- Celecoxib
- 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
SC 58635- SC 58635
- 58635, SC
- SC-58635
- SC58635
|
Below are MeSH descriptors whose meaning is more general than "Celecoxib".
Below are MeSH descriptors whose meaning is more specific than "Celecoxib".
This graph shows the total number of publications written about "Celecoxib" by people in this website by year, and whether "Celecoxib" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 2 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Celecoxib" by people in Profiles.
-
Structural investigation on the selective COX-2 inhibitors mediated cardiotoxicity: A review. Life Sci. 2020 Jun 15; 251:117631.
-
Clinically Relevant Anti-Inflammatory Agents for Chemoprevention of Colorectal Cancer: New Perspectives. Int J Mol Sci. 2018 Aug 08; 19(8).
-
A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 05; 145(2):291-297.
-
Angiogenic inhibition reduces germinal matrix hemorrhage. Nat Med. 2007 Apr; 13(4):477-85.
-
Celecoxib versus a non-selective NSAID plus proton-pump inhibitor: what are the considerations?. J Pain Palliat Care Pharmacother. 2006; 20(4):11-32.
-
Bleeding complications in patients on celecoxib and warfarin. J Clin Pharm Ther. 2005 Oct; 30(5):471-7.
-
Celecoxib-induced upper gastrointestinal hemorrhage and ulceration. South Med J. 2002 Dec; 95(12):1444-6.
-
Bioactivity of alkamides isolated from Echinacea purpurea (L.) Moench. Phytomedicine. 2002 Apr; 9(3):249-53.